The intravenous methods targets nutrients directly to where they are needed
Further large-scale trials/studies are needed for longer durations to validate the use of these systemic agents for the treatment of melasma, thus, enriching our therapeutic armamentarium
Austin, P
Cabungcal JH, Preissmann D, Delseth C, Cunod M, Do KQ, Schenk F
Once BPC-157 is administered, the healing process begins
One of his own longtime collaborators, Sandor Szabo, has gone further, allowing in print that the original team may have misread an amino acid sequence back in the late 1980s, when the chemistry was cruder